BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35446161)

  • 21. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis.
    Tong Z; Guo L; Qi L; Cui S; Gao X; Li Y; Guo J; Gu Y
    Biomed Res Int; 2020; 2020():3076346. PubMed ID: 32596293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.
    Jiang X; Fan L; Chen B; Jiang J; Liu J; Qiao G; Ju S; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Dong Z; Fu W
    BMC Cardiovasc Disord; 2022 Jul; 22(1):317. PubMed ID: 35842583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.
    Cassese S; Ndrepepa G; Kufner S; Byrne RA; Giacoppo D; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    EuroIntervention; 2017 Jul; 13(4):483-489. PubMed ID: 28169215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Excimer Laser Ablation Combined with Drug-coated Balloon in Atherosclerotic Lesions of the Popliteal Artery.
    Jiang X; Ju S; Liu H; Chen B; Jiang J; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Fu W; Dong Z
    Ann Vasc Surg; 2024 Jul; 104():196-204. PubMed ID: 38492729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study.
    Shammas NW; Petruzzi N; Henao S; Armstrong EJ; Shimshak T; Banerjee S; Latif F; Eaves B; Brothers T; Golzar J; Shammas GA; Jones-Miller S; Christensen L; Shammas WJ
    J Endovasc Ther; 2021 Feb; 28(1):107-116. PubMed ID: 32885736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study.
    Jia S; Liu J; Sun G; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Ann Vasc Surg; 2022 May; 82():70-80. PubMed ID: 34902474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of Rotarex
    Pan T; Tian SY; Liu Z; Zhang T; Li C; Ji DH
    Ann Vasc Surg; 2022 Mar; 80():213-222. PubMed ID: 34748945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
    Feng Z; Yang S; Sang H; Xue G; Ni Q; Zhang L; Zhang W; Fang X; Ye M
    J Endovasc Ther; 2021 Dec; 28(6):927-937. PubMed ID: 34251279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of Different Endovascular Treatments of Femoropopliteal Artery In-Stent Restenosis: A Systematic Review and Bayesian Network Meta-Analysis.
    Wang H; Wu S; D'Oria M; Pan D; Hu L; Zhang H; Guo J; Gu Y
    Ann Vasc Surg; 2024 Jul; 104():205-216. PubMed ID: 38492725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Angioscopic Evaluation for Femoropopliteal In-Stent Restenosis Before and After Excimer Laser Atherectomy.
    Idemoto A; Okamoto N; Tanaka A; Mori N; Nakamura D; Yano M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    Vasc Endovascular Surg; 2017 Jul; 51(5):335-337. PubMed ID: 28486842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
    Haraguchi T; Kuramitsu S; Tsujimoto M; Kashima Y; Sato K; Fujita T
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):97-105. PubMed ID: 37975201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical coherence tomography guided directional atherectomy with antirestenotic therapy for femoropopliteal arterial disease.
    Stavroulakis K; Bisdas T; Torsello G; Argyriou A; Bollenberg L; Schwindt A
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):191-197. PubMed ID: 30665284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
    Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.